耐力运动员的心房心肌病
L W Spencer1,2, P D'Ambrosio1,2,3, M Ohanian4
1St Vincent's Institute, Fitzroy, Victoria, Australia.
NPJ cardiovascular health
|March 3, 2026
概括
运动员的心房肌病症显示结构和电气变化. 虽然这些变化往往是生理性的,但可能会增加心房的风险,影响运动员的健康管理.
科学领域:
- 心脏病学 心脏病学
- 运动医学 运动医学
- 生理学 生理学 生理学
背景情况:
- 心房心肌病症涉及心房重塑,增加心律失常和中风风险.
- 运动员的心脏描述了耐力运动员的心房变化,包括大小和功能的改变.
- 耐力运动员有已知的心房动风险,尽管运动员的心脏通常是良性的.
研究的目的:
- 审查运动员中心房肌病的临床特征,原因和后果.
- 探索运动员心脏中的生理适应和病理之间的模两可.
- 突出心房心肌病在运动员预后和管理中的重要性.
主要方法:
- 关于运动员心房肌病的当前研究的文献综述.
- 对耐力运动员常见的左心房观察结果的分析.
- 检查耐力运动和心房重塑之间的关系.
主要成果:
- 运动员表现出较大的左心房体积,较低的心房体积比率,心房应变减少,心房外皮增加.
- 运动员心脏的生理适应和病理变化之间的区别仍然不清楚.
- 尽管有良性感觉,但运动员的心脏与心房动风险增加有关.
结论:
- 前庭心肌病是运动员预后和管理的关键考虑因素.
- 了解运动员心房重塑对于区分适应与疾病至关重要.
- 需要进一步的研究来澄清心房变化对耐力运动员的影响.
相关概念视频
Myocarditis I: Introduction
645
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
Cardiomyopathy I: Introduction and Classification
826
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy
952
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753


